<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/23454317-ADC4-4369-A212-BF0802191E59"><gtr:id>23454317-ADC4-4369-A212-BF0802191E59</gtr:id><gtr:name>Domainex</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/53C305A8-5DF2-4008-A679-E39E331B1DB1"><gtr:id>53C305A8-5DF2-4008-A679-E39E331B1DB1</gtr:id><gtr:name>James Leckey Design</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/23454317-ADC4-4369-A212-BF0802191E59"><gtr:id>23454317-ADC4-4369-A212-BF0802191E59</gtr:id><gtr:name>Domainex</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/53C305A8-5DF2-4008-A679-E39E331B1DB1"><gtr:id>53C305A8-5DF2-4008-A679-E39E331B1DB1</gtr:id><gtr:name>James Leckey Design</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A159BFCD-0A2C-4BC3-9CEA-573ACE508A6F"><gtr:id>A159BFCD-0A2C-4BC3-9CEA-573ACE508A6F</gtr:id><gtr:firstName>James</gtr:firstName><gtr:surname>McElnay</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_15061"><gtr:id>C0BB24A3-6916-46F2-8B4F-5E893270755F</gtr:id><gtr:title>Integrating Industry Engagement into the Vision for Queen?s Biomedical Research in 2020</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_15061</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>The MRC Proximity to Discovery scheme awards universities funds to help develop new collaborations, and ways of exchanging knowledge and skills.&amp;nbsp; The awards can be used to support activities that promote the value of academic-industry partnership, and enhance academic and industry researchers? understanding of each other?s needs and capabilities.&amp;nbsp; This may be through people exchanges, creation of technology demonstrators, showcase events, commercialisation workshops and ?entrepreneurs in residence? schemes.&amp;nbsp; Such exchanges of knowledge and skills will boost the most fruitful collaborations between UK universities and life science companies.</gtr:technicalSummary><gtr:fund><gtr:end>2017-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2016-03-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>200000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>James Leckey Design</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Improving the lives of children with disabilities using postural support equipment: scoping collaborative industry-academic-clinical opportunities (Dr C Kerr)</gtr:description><gtr:id>9CC1AACD-9675-4C87-9D3E-E13EE6188E76</gtr:id><gtr:impact>No outputs as yet.</gtr:impact><gtr:outcomeId>58be871e3ffe88.10262061-1</gtr:outcomeId><gtr:partnerContribution>Leckey will commit staff time and resources to developing a relationship with Dr Kerr and NHS clinicians to explore mutual interests with QUB primarily investigating the efficacy, effectiveness and acceptability of supportive postural equipment for children and young people with disabilities and therapeutic programs to enhance the use of such equipment.</gtr:partnerContribution><gtr:piContribution>This project will enable the QUB academic (Dr Kerr), with a track record in clinical and health services research with children with disabilities, to engage with Leckey, conduct knowledge transfer activities with healthcare professionals and to scope possibilities for future collaborative work that will be of mutual relevance.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Proof of concept study to evaluate the application of novel GSK protease inhibitors in cystic fibrosis (Dr L Martin)</gtr:description><gtr:id>DD587F03-7F56-4349-A208-E5469937AAA7</gtr:id><gtr:impact>No outputs as yet.</gtr:impact><gtr:outcomeId>58be9e602dbbf3.58195107-1</gtr:outcomeId><gtr:partnerContribution>GSK will be collaborating with QUB to explore the potential of CF as a secondary indication for clinical use for a library of their compounds. GSK will provide QUB access to a range of specific and highly selective compounds. GSK will host a QUB PhD student for 1 month industrial placement where they will work in the furin inhibitor research group; an area which is directly relevant to their PhD studies.</gtr:partnerContribution><gtr:piContribution>The QUB research group will undertake a Relationship Development Pilot Project with GSK (USA) in order to evaluate novel GSK compounds in the context of cystic fibrosis. QUB will demonstrate to GSK the utility of their in-house models. This pilot project will contribute to the strategic relationship that QUB has built with GSK through expansion into another disease area.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Domainex</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Targeting biofilm associated proteases in acinetobacte baumannii: developing selective, non-antibiotic anti-biofilm compounds (Dr Williams &amp;amp; Prof Gilmore)</gtr:description><gtr:id>C9443225-8FDB-4E4A-8031-82BB8104D1CD</gtr:id><gtr:impact>No outputs as yet</gtr:impact><gtr:outcomeId>58c16b633cad94.04916315-1</gtr:outcomeId><gtr:partnerContribution>Domainex are supporting the P2D project by assisting in the selection and design of molecules to explore structural activity relationship around the hit compounds identified and developed. Domainex will host the QUB PDRA for a period of time to carry out laboratory work at their facilities. In addition, Domainex plan to conduct a seminar at QUB in order to develop closer ties with QUB, and to meet with other groups within QUB that are preparing projects for various funding streams (e.g. MRC DPFS etc).</gtr:partnerContribution><gtr:piContribution>A relationship development pilot project between QUB and Domainex will be carried out. The aim is to develop potent, highly selective inhibitors of the target proteases which will reduce biofilm formation and increase antimicrobial sensitivity of A. baumannii biofilms during chronic infection and surface decolonisation. All objectives will be guided by discussions with Domainex, ensuring at all times that outputs align with industry.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_15061</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C4255A20-7C03-4147-BA26-8D72C9457F1C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Health Uncodeable</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>06E85C67-BEDD-4C93-990D-B74FCF876924</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Research Uncodeable</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>